Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?

Study identification

• EU PAS number:
  EUPAS33148
• Study ID:
  33722
• Official title and acronym:
  Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  Exploring and combining results from more than one real world data (RWD) source might be necessary in order to explore variability and demonstrate generalisability of the results, or for regulatory requirements. However, the heterogeneous nature of RWD poses challenges when working with more than one source, some of which can be solved by analysing databases converted into a common data model (CDM).The main objective of the study was to evaluate the implementation of the Observational Medical Outcome Partnership (OMOP) CDM on IQVIA Medical Research Data (IMRD) UK data. A drug utilisation study describing the prescribing of codeine for pain in children was used as a case study to be replicated in IMRD-UK and its corresponding OMOP CDM transformation. Differences between IMRD-UK source and OMOP CDM were identified and investigated.
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned:02/07/2018

Actual:02/07/2018

Study start date

Planned:02/07/2018

Actual:02/07/2018

Data analysis start date

Planned:02/07/2018

Actual:02/07/2018

Date of final study report

Planned:16/09/2019

Actual:16/09/2019

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable